|
|
|
Insider
Information: |
Zachary Jennifer |
Relationship: |
|
City: |
Kenilworth |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
38,564 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,959,467 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
38,564 |
|
|
Total
Value |
$3,959,467 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Merck & Co Inc |
MRK |
EVP, General Counsel |
2024-02-02 |
29,058 |
|
0 |
Premium* |
|
Regenxbio Inc. |
RGNX |
|
2023-06-02 |
9,506 |
2022-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2019-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,772 |
5,772 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2019-05-04 |
4 |
D |
$80.00 |
$172,320 |
D/D |
(2,154) |
3,618 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2020-05-04 |
4 |
OE |
$77.67 |
$448,311 |
D/D |
5,772 |
9,489 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2020-05-04 |
4 |
D |
$77.67 |
$220,816 |
D/D |
(2,843) |
6,646 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2021-02-26 |
4 |
A |
$72.62 |
$1,757,331 |
D/D |
24,199 |
30,947 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2021-05-04 |
4 |
D |
$75.98 |
$216,011 |
D/D |
(2,843) |
34,141 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2021-05-04 |
4 |
OE |
$75.98 |
$438,557 |
D/D |
5,772 |
36,984 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2022-02-24 |
4 |
A |
$73.51 |
$1,354,054 |
D/D |
18,420 |
53,419 |
0 |
- |
|
RGNX |
Regenxbio Inc. |
|
|
2022-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,020 |
6,020 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2022-10-28 |
4 |
S |
$99.07 |
$16,422,893 |
D/D |
(165,255) |
38,040 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2022-10-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
148,647 |
203,295 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2023-01-23 |
4 |
A |
$109.88 |
$1,717,534 |
D/D |
15,631 |
53,920 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2023-02-03 |
4 |
OE |
$56.04 |
$4,227,433 |
D/D |
75,436 |
129,356 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2023-02-03 |
4 |
S |
$103.17 |
$7,782,762 |
D/D |
(75,436) |
53,920 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2023-05-04 |
4 |
S |
$117.59 |
$2,250,834 |
D/D |
(19,141) |
35,128 |
0 |
- |
|
RGNX |
Regenxbio Inc. |
|
|
2023-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,486 |
9,506 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2024-01-22 |
4 |
A |
$119.43 |
$2,782,480 |
D/D |
23,298 |
59,140 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2024-02-02 |
4 |
OE |
$87.10 |
$1,691,221 |
D/D |
19,417 |
78,557 |
0 |
- |
|
MRK |
Merck & Co Inc |
EVP, General Counsel |
|
2024-02-02 |
4 |
S |
$126.97 |
$6,284,779 |
D/D |
(49,499) |
29,058 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|